在不同类型的痴呆症中共享的神经炎症机制:综合性审查
Subramanian Thangaleela1, Asif Ali1, Yohanes Tandoro2
1Department of Nutrition, Chung Shan Medical University, 110, Sec. 1, Jianguo North Road, Taichung City 40201, Taiwan, China.
International journal of molecular sciences
|January 10, 2026
概括
神经炎症是痴呆症病原体的核心,影响各种类型痴呆症的认知衰退. 针对共享的炎症途径为痴呆症治疗提供了有前途的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 免疫学 免疫学 免疫学
- 病理学 病理学 病理学
背景情况:
- 痴呆症是一种全球性神经退行性疾病,其特点是渐进性的认知能力下降.
- 不同类型的痴呆症具有共同的炎症途径,包括微质细胞和天体细胞激活.
- 由亲炎性细胞因子驱动的神经炎症,有助于突触功能障碍和神经元退化.
研究的目的:
- 探索将神经炎症与各种类型的痴呆症联系在一起的复杂机制.
- 在不同痴呆症中识别共享和独特的神经炎症路径.
- 揭开潜在的治疗策略,针对痴呆症中神经炎症.
主要方法:
- 审查关于痴呆症病原和神经炎症的当前文献.
- 分析共享和独特的炎症媒介和细胞反应.
- 检查神经成像和生物标志物发现治疗点的进展.
主要成果:
- 神经炎症是所有痴呆症形式的发病的一个关键因素.
- 激活的微质细胞和星球细胞释放促炎细胞因子,加剧神经元损伤.
- 尽管病理多样化,但常见的炎症过程会导致认知能力下降.
结论:
- 分享的神经炎症机制为各种痴呆症提供了统一的治疗点.
- 了解不同的炎症途径可能会导致量身定制的痴呆症治疗.
- 针对神经炎症具有缓解痴呆症进展的巨大潜力.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Dementia
511
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
511
Alzheimer's Disease: Treatment
806
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
806
Neural Regulation
43.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.1K
Role of Neurotransmitters in Memory
2.5K
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
2.5K


